San Francisco, CA- based solution for behavior-based healthcare pricing, Sempre Health, closed its $8M series A financing.
The funding round was led by Rethink Impact with participation from Social Capital and others.
The company intends to use the funds to accelerate the growth of its two-sided affordability marketplace.
Led by Anurati Mathur, CEO, Sempre Health operates a two-sided network of payers and pharma manufacturers. Unlike traditional coupons and vouchers, Sempre works with multiple healthcare stakeholders to dynamically adjust a patient’s co-payment based on proper adherence and behavior, seamlessly at the point of fill.
Sempre Health’s innovative and dynamic discount programs enable health plans to financially align members with broader clinical priorities, by allowing them to pay less when they take responsible actions, such as filling their prescriptions on time. Members can drive their costs down over time using their behavior as a lever. It allows health plans to select the medicines to make available. Therefore every program is consistent with the formulary design and tied to reductions in the overall cost of care. It is the first startup to generate the first ever real-world dataset on patient price sensitivities and cost behavior.
Earlier this year, the company announced its partnership with Novo Nordisk to bring dynamic discounts and engagement to diabetes patients across the country. Sempre will have more than 15 pharma manufacturer and payer partners by Q4’18.